Ancilia Biosciences, Inc.

Other · NEW YORK, NY

OtherSEC Form D

Ancilia Biosciences, Inc. filed a Form D with the U.S. Securities and Exchange Commission on April 6, 2026, reporting $10,076,464 raised.

Incorporated in Delaware and based in NEW YORK, NY, it operates in the Other sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Ancilia Biosciences, Inc. has raised capital from private investors.

Browse more recently funded companies in Other.

Executives & Directors

  • ALEXANDRA SAKATOSExecutive Officer · Director
  • RODOLPHE BARRANGOUExecutive Officer · Director
  • DALE PFOSTDirector
  • VERA SCHROEDERDirector
  • GURDANE BHUTANIDirector

Recently funded in Other

Other companies that recently filed a Form D

$2.7MRaised

Civic Media, Inc.

OtherMADISON, WI
Jun 2, 2026View SEC Form D
$4.0MRaised

Aviation Equity LLC

OtherFayetteville, AR
May 28, 2026View SEC Form D
$2.5MRaised

BNB PLUS CORP.

OtherSTONY BROOK, NY
May 28, 2026View SEC Form D
$11.5MRaised

Milestone Capital Partners, Inc.

OtherTROY, MI
May 28, 2026View SEC Form D
$487.5KRaised

Minnie's Golf LLC

OtherBIRMINGHAM, AL
May 27, 2026View SEC Form D
Ancilia Biosciences, Inc. raised $10.1M — SEC Form D